1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) News

AGIO

Agios Pharmaceuticals Inc
22.97
0.42 (1.86%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Agios Pharmaceuticals Inc AGIO NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
0.42 1.86% 22.97 11:00:00
Open Price Low Price High Price Close Price Previous Close
22.62 22.62 23.39 22.97 22.55
more quote information »

Recent News

Date Time Source Heading
04/3/202308:12EDGARCurrent Report Filing (8-k)
04/3/202308:08EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202308:08EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
04/3/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
03/3/202300:26GLOBEAgios to Participate in March Investor Conferences
02/3/202308:08EDGARStatement of Changes in Beneficial Ownership (4)
28/2/202323:00GLOBEAgios Launches “Red Cell Revolution” in Recognition of Rare..
24/2/202308:24EDGARSecurities Registration: Employee Benefit Plan (s-8)
24/2/202302:36EDGARAnnual Report (10-k)
23/2/202323:00GLOBEAgios Reports Fourth Quarter and Full Year 2022 Financial..
22/2/202308:06EDGARStatement of Changes in Beneficial Ownership (4)
17/2/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
17/2/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
17/2/202308:07EDGARStatement of Changes in Beneficial Ownership (4)
15/2/202308:38EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202308:29EDGARStatement of Changes in Beneficial Ownership (4)
15/2/202308:20EDGARStatement of Changes in Beneficial Ownership (4)
15/2/202308:12EDGARStatement of Changes in Beneficial Ownership (4)
15/2/202306:51EDGARStatement of Ownership (sc 13g)
15/2/202304:41EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202303:55EDGARStatement of Ownership (sc 13g)
10/2/202303:03EDGARAmended Statement of Ownership (sc 13g/a)
09/2/202301:25EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202306:44EDGARSchedule 13g
(sc 13g/a)
04/2/202308:07EDGARAnnual Statement of Changes in Beneficial Ownership (5)
02/2/202323:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
02/2/202308:05EDGARStatement of Changes in Beneficial Ownership (4)
26/1/202302:39EDGARAmended Statement of Ownership (sc 13g/a)
19/1/202308:10EDGARStatement of Changes in Beneficial Ownership (4)
09/1/202323:20EDGARCurrent Report Filing (8-k)
09/1/202312:00GLOBEAgios Unveils 2023-2026 Value-driving Catalysts Enabling..
06/1/202308:11EDGARStatement of Changes in Beneficial Ownership (4)
04/1/202309:57GLOBEAgios Reports Inducement Grants Under Nasdaq Listing Rule..
04/1/202309:22EDGARSecurities Registration: Employee Benefit Plan (s-8)
22/12/202200:00GLOBEAgios to Present at 41st Annual J.P. Morgan Healthcare..
17/12/202208:03EDGARCurrent Report Filing (8-k)
12/12/202211:00GLOBEAgios Presents Updated PYRUKYND® (mitapivat) Long-term..
11/12/202210:30GLOBEAgios Presents Updated PYRUKYND® (mitapivat) Data..
07/12/202208:15EDGARStatement of Changes in Beneficial Ownership (4)
06/12/202223:37EDGARCurrent Report Filing (8-k)
06/12/202223:00GLOBEAgios Appoints Tsveta Milanova as Chief Commercial Officer
01/12/202200:00GLOBEAgios to Participate in December Investor Conference
11/11/202208:01GLOBEPYRUKYND® (mitapivat) Approved in the EU for the Treatment..
07/11/202214:26TRMNSVB Securities Reaffirms Their Buy Rating on Agios Pharma..
04/11/202200:47EDGARQuarterly Report (10-q)
04/11/202200:00GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
03/11/202222:03EDGARCurrent Report Filing (8-k)
03/11/202222:00GLOBEAgios Reports Business Highlights and Third Quarter 2022..
31/10/202215:26TRMNSVB Securities Reaffirms Their Buy Rating on Agios Pharma..
Your Recent History
NASDAQ
AGIO
Agios Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230402 05:46:21